RAJENDER APARASU to Immunologic Factors
This is a "connection" page, showing publications RAJENDER APARASU has written about Immunologic Factors.
Connection Strength
1.436
-
DIscontinuation of disease-modifying therapies in older adults with multiple sclerosis. Mult Scler Relat Disord. 2026 Sep; 113:107378.
Score: 0.867
-
Comparative effectiveness of high-efficacy and moderate efficacy disease-modifying agents in reducing the annualized relapse rates among multiple sclerosis patients in the United States. Prev Med. 2025 01; 190:108180.
Score: 0.193
-
Factors associated with the initiation of high-efficacy disease-modifying agents over moderate-efficacy disease-modifying agents in multiple sclerosis. Mult Scler Relat Disord. 2024 Nov; 91:105896.
Score: 0.191
-
Association of oral disease-modifying agents and their adherence trajectories with annual relapses in multiple sclerosis. Mult Scler Relat Disord. 2024 May; 85:105539.
Score: 0.185